Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience

Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience Cardiol Ther (2015) 4:197–201 DOI 10.1007/s40119-015-0050-2 BRIEF REPORT Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience . . . . Jeffrey E. Rossi Andrew Noll Brian Bergmark James M. McCabe . . . . David Nemer David R. Okada Anant Vasudevan Michael Davidson . . . Frederick Welt Andrew Eisenhauer Pinak Shah Robert Giugliano To view enhanced content go to www.cardiologytherapy-open.com Received: August 21, 2015 / Published online: September 23, 2015 The Author(s) 2015. This article is published with open access at Springerlink.com Results: Of a total of 255 patients undergoing ABSTRACT the procedure, 132 (51%) had an indication for Introduction: The aim of this study was to anticoagulation pre-TAVR and 92 (70% of those describe peri-procedural antithrombotic use in with an indication) were on treatment. On patients undergoing transcatheter aortic valve discharge, 106 patients (44% of total surviving replacement (TAVR) at a single academic to discharge, 73% of those surviving with an medical center. indication for anticoagulation) were treated Methods: Retrospective collection of with oral anticoagulation. Of these patients, antiplatelet and anticoagulant use during the 89 (84%) were discharged on aspirin and an oral index hospitalization for all patients anticoagulant without clopidogrel. Only 122 undergoing http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cardiology and Therapy Springer Journals

Loading next page...
 
/lp/springer-journals/variability-in-antithrombotic-therapy-regimens-peri-tavr-a-single-QmsB5ojRL1

References (15)

Publisher
Springer Journals
Copyright
Copyright © 2015 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Cardiology
ISSN
2193-8261
eISSN
2193-6544
DOI
10.1007/s40119-015-0050-2
pmid
26399647
Publisher site
See Article on Publisher Site

Abstract

Cardiol Ther (2015) 4:197–201 DOI 10.1007/s40119-015-0050-2 BRIEF REPORT Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience . . . . Jeffrey E. Rossi Andrew Noll Brian Bergmark James M. McCabe . . . . David Nemer David R. Okada Anant Vasudevan Michael Davidson . . . Frederick Welt Andrew Eisenhauer Pinak Shah Robert Giugliano To view enhanced content go to www.cardiologytherapy-open.com Received: August 21, 2015 / Published online: September 23, 2015 The Author(s) 2015. This article is published with open access at Springerlink.com Results: Of a total of 255 patients undergoing ABSTRACT the procedure, 132 (51%) had an indication for Introduction: The aim of this study was to anticoagulation pre-TAVR and 92 (70% of those describe peri-procedural antithrombotic use in with an indication) were on treatment. On patients undergoing transcatheter aortic valve discharge, 106 patients (44% of total surviving replacement (TAVR) at a single academic to discharge, 73% of those surviving with an medical center. indication for anticoagulation) were treated Methods: Retrospective collection of with oral anticoagulation. Of these patients, antiplatelet and anticoagulant use during the 89 (84%) were discharged on aspirin and an oral index hospitalization for all patients anticoagulant without clopidogrel. Only 122 undergoing

Journal

Cardiology and TherapySpringer Journals

Published: Sep 23, 2015

There are no references for this article.